The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway
- PMID: 22554805
- DOI: 10.1124/mol.111.076687
The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway
Abstract
Levetiracetam (LEV) is a prominent antiepileptic drug that binds to neuronal synaptic vesicle glycoprotein 2A protein and has reported effects on ion channels, but with a poorly defined mechanism of action. We investigated inhibition of voltage-dependent Ca(2+) (Ca(V)) channels as a potential mechanism through which LEV exerts effects on neuronal activity. We used electrophysiological methods to investigate the effects of LEV on cholinergic synaptic transmission and Ca(V) channel activity in superior cervical ganglion neurons (SCGNs). In parallel, we investigated the effects of the inactive LEV R-enantiomer, (R)-α-ethyl-2-oxo-1-pyrrolidine acetamide (UCB L060). LEV but not UCB L060 (each at 100 μM) inhibited synaptic transmission between SCGNs in long-term culture in a time-dependent manner, significantly reducing excitatory postsynaptic potentials after a ≥30-min application. In isolated SCGNs, LEV pretreatment (≥1 h) but not short-term application (5 min) significantly inhibited whole-cell Ba(2+) current (I(Ba)) amplitude. In current-clamp recordings, LEV reduced the amplitude of the afterhyperpolarizing potential in a Ca(2+)-dependent manner but also increased the action potential latency in a Ca(2+)-independent manner, which suggests additional mechanisms associated with reduced excitability. Intracellular LEV application (4-5 min) caused rapid inhibition of I(Ba) amplitude, to an extent comparable to that seen with extracellular LEV pretreatment (≥1 h). Neither pretreatment nor intracellular application of UCB L060 produced any inhibitory effects on I(Ba) amplitude. These results identify a stereospecific intracellular pathway through which LEV inhibits presynaptic Ca(V) channels; resultant reductions in neuronal excitability are proposed to contribute to the anticonvulsant effects of LEV.
Similar articles
-
Inhibition of excitatory synaptic transmission in hippocampal neurons by levetiracetam involves Zn²⁺-dependent GABA type A receptor-mediated presynaptic modulation.J Pharmacol Exp Ther. 2014 Feb;348(2):246-59. doi: 10.1124/jpet.113.208751. Epub 2013 Nov 20. J Pharmacol Exp Ther. 2014. PMID: 24259680
-
The antiepileptic drug levetiracetam decreases the inositol 1,4,5-trisphosphate-dependent [Ca2+]I increase induced by ATP and bradykinin in PC12 cells.J Pharmacol Exp Ther. 2005 May;313(2):720-30. doi: 10.1124/jpet.104.079327. Epub 2005 Jan 11. J Pharmacol Exp Ther. 2005. PMID: 15644427
-
Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder.J Pharmacol Exp Ther. 2024 Sep 18;391(1):104-118. doi: 10.1124/jpet.124.002272. J Pharmacol Exp Ther. 2024. PMID: 39060163
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article. Review.
-
Exploring conceptual and theoretical frameworks for nurse practitioner education: a scoping review protocol.JBI Database System Rev Implement Rep. 2015 Oct;13(10):146-55. doi: 10.11124/jbisrir-2015-2150. JBI Database System Rev Implement Rep. 2015. PMID: 26571290
Cited by
-
Levetiracetam in neonatal seizures: a review.J Pediatr Pharmacol Ther. 2015 Mar-Apr;20(2):76-89. doi: 10.5863/1551-6776-20.2.76. J Pediatr Pharmacol Ther. 2015. PMID: 25964725 Free PMC article. Review.
-
Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer's disease.Metab Brain Dis. 2022 Mar;37(3):689-700. doi: 10.1007/s11011-021-00888-0. Epub 2022 Jan 31. Metab Brain Dis. 2022. PMID: 35098412
-
Trigeminal Neuralgia: Current Approaches and Emerging Interventions.J Pain Res. 2021 Nov 3;14:3437-3463. doi: 10.2147/JPR.S331036. eCollection 2021. J Pain Res. 2021. PMID: 34764686 Free PMC article. Review.
-
Levetiracetam in the management of feline audiogenic reflex seizures: a randomised, controlled, open-label study.J Feline Med Surg. 2017 Feb;19(2):200-206. doi: 10.1177/1098612X15622806. Epub 2016 Jul 9. J Feline Med Surg. 2017. PMID: 26690830 Free PMC article.
-
Hallmarks of cancer-the new testament.Open Biol. 2021 Jan;11(1):200358. doi: 10.1098/rsob.200358. Epub 2021 Jan 20. Open Biol. 2021. PMID: 33465324 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous